Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|May 26, 2021
Estimates of future cancer mortality attributable to modifiable risk factors in CanadaJoy Pader, Yibing Ruan, Abbey E Poirier, et al.
International Journal of Cancer|May 1, 2021
The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project)Eileen Morgan, Melina Arnold, Mark J Rutherford, et al.
International Journal of Cancer|August 30, 2021
Comparison of liver cancer incidence and survival by subtypes across seven high-income countriesMark J Rutherford, Melina Arnold, Aude Bardot, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|May 26, 2021
Estimating the future cancer management costs attributable to modifiable risk factors in CanadaYibing Ruan, Abbey E Poirier, Joy Pader, et al.
Preventive Medicine|May 13, 2019
The burden of cancer attributable to modifiable risk factors in Canada: Methods overviewDarren R Brenner, Christine M Friedenreich, Yibing Ruan, et al.
British Journal of Cancer|March 3, 2022
Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based studyCitadel J Cabasag, Melina Arnold, Mark Rutherford, et al.
BMJ Open|August 3, 2018
Estimating the current and future cancer burden in Canada: methodological framework of the Canadian population attributable risk of cancer (ComPARe) studyDarren R Brenner, Abbey E Poirier, Stephen D Walter, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|December 11, 2020
A comparative analysis: international variation in PET-CT service provision in oncology-an International Cancer Benchmarking Partnership studyCharlotte Lynch, Irene Reguilon, Deanna L Langer, et al.
International Journal of Cancer|October 2, 2020
Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based studySophie Pilleron, Hadrien Charvat, Marzieh Araghi, et al.
Thorax|July 20, 2021
International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 StudyMarzieh Araghi, Miranda Fidler-Benaoudia, Melina Arnold, et al.
Pageof 6